ProCE Banner Activity

Podcast Pearls
TKIs for Advanced HCC in the Second Line and Beyond

Slideset Download
Summary slides for a podcast where Josep M. Llovet, MD, PhD, and Markus Peck-Radosavljevic, MD, MBA, discuss the role of tyrosine kinase inhibitors in the second-line treatment of patients with advanced hepatocellular carcinoma.

Released: February 22, 2022

Expiration: February 21, 2023

No longer available for credit.
Begin Activity

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Bayer Healthcare Pharma